Comparison
6q Terminal Deletion Syndrome C4304514 vs 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Clinical comparison between 6Q Terminal Deletion Syndrome and 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia for differential diagnosis and treatment planning.
6q Terminal Deletion Syndrome C4304514
A chromosomal disorder involving deletion of genetic material at the end of chromosome 6, leading to developmental delays and variable physical features.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
An inherited disorder affecting adrenal hormone production, causing cortisol deficiency and other hormonal imbalances. Features may include ambiguous genitalia, salt-wasting crises, and growth issues. Treated with lifelong hormone replacement therapy.
6 comparison axes
Onset
6q Terminal Deletion Syndrome C4304514
0-0
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
0-null
Onset patterns differ
Severity
6q Terminal Deletion Syndrome C4304514
severe
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
severe
Different severity levels
Chronic
6q Terminal Deletion Syndrome C4304514
Chronic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Chronic
Differing course
Communicable
6q Terminal Deletion Syndrome C4304514
No
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
No
Different transmission
Body System
6q Terminal Deletion Syndrome C4304514
congenital
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
Same/different system
Category
6q Terminal Deletion Syndrome C4304514
genetic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
Different category
Bottom line
6q-terminal-deletion-syndrome-C4304514 and 21-hydroxylase-deficient-congenital-adrenal-hyperplasia-C2936858 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 6q Terminal Deletion Syndrome C4304514 | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | Discriminating power |
|---|---|---|---|
| Development | Developmental delay is a described core feature, with variable severity. | Hormone imbalance is primary; developmental delay is not the defining feature. | High |
| Adrenal crisis | Salt-wasting crisis is not characteristic of the chromosomal deletion. | Salt-wasting crisis, dehydration, or shock may occur in severe forms. | High |
| Genital and growth features | Physical features vary and are not specifically adrenal in origin. | Ambiguous genitalia, androgen effects, or growth issues may occur. | Moderate |
When to favor each condition
Choose 6q Terminal Deletion Syndrome C4304514 when
A terminal 6q deletion is confirmed
Chromosomal testing directly supports this genetic diagnosis.
High
Congenital anomalies with developmental delay
This pattern fits the supplied chromosomal phenotype better than isolated adrenal disease.
Moderate
No biochemical adrenal-disorder pattern
Absence of CAH biochemistry makes the deletion diagnosis more plausible, but does not prove it.
Moderate
Choose 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 when
Abnormal adrenal steroid results with compatible features
Biochemistry plus clinical findings supports 21-hydroxylase deficiency; use laboratory reference ranges.
High
Pathogenic CYP21A2 result
Disease-gene testing can confirm the inherited adrenal disorder when interpreted clinically.
High
Suspected salt-wasting illness
Urgent endocrine evaluation is appropriate because cortisol and aldosterone deficiency may be life-threatening.
Moderate
How key tests differ
| Test | 6q Terminal Deletion Syndrome C4304514 | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | Terminal deletion involving 6q may be identified. | Chromosomes are usually not the diagnostic abnormality. | A deletion supports the left diagnosis but does not exclude a separate endocrine disorder. |
| Adrenal steroid profile, including 17-hydroxyprogesterone | No CAH-specific pattern is established by the source description. | 17-hydroxyprogesterone is typically elevated; exact cutoffs are not supplied. | Interpret only against the laboratory reference range and clinical context. |
| CYP21A2 genetic testing | Not the primary diagnostic test for a chromosomal deletion. | Pathogenic variants can support 21-hydroxylase deficiency. | Genetic results need correlation with phenotype and biochemistry. |
Prognosis comparison
6q Terminal Deletion Syndrome C4304514
- Outcome
- Chronic and variable; many people need ongoing developmental and medical support. Exact prognosis is not established.
- Factors
- Deletion extent, associated anomalies, comorbidities, and access to therapy.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
- Outcome
- Chronic but often manageable with lifelong hormone replacement; salt-wasting forms carry acute risk.
- Factors
- Phenotype severity, treatment adherence, intercurrent illness, and specialist monitoring.
Time frame: Lifelong, often recognized in infancy or early childhood.
Early recognition, coordinated care, family education, and individualized follow-up.
Complications comparison
| Complication | Presentation |
|---|---|
| Acute adrenal insufficiency | Not a characteristic complication in the supplied description. Salt-wasting crisis can cause severe dehydration or shock. Urgent care is required for suspected adrenal crisis; this comparison does not provide treatment doses. |
| Neurodevelopment | Developmental delay and disability may be substantial and variable. Neurodevelopment is not the defining issue, although illness can affect wellbeing. Support needs should be individualized; exact outcomes are not established here. |
| Growth and puberty | Growth or physical differences may occur but are variable. Androgen excess or treatment effects may influence growth and puberty. Endocrine monitoring is relevant for CAH; no definitive growth pattern is supplied. |
Patient education highlights
- HighDifferent diagnoses
A chromosomal deletion and adrenal hormone disorder require different specialist testing and care.
- HighEmergency symptoms
For suspected CAH, vomiting, dehydration, lethargy, or shock needs urgent medical assessment.
- MediumLong-term support
Families may need genetics counseling, developmental services, endocrine follow-up, and sick-day planning.